CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- DEF 14A Proxy Proxy Statement
- PRER14A Other PRER14A
- PRE 14A Proxy Proxy Statement (Preliminary)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Option exercise Director acquired 194,134 shares (option exercise)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 3 Insider Initial Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Other events
- 8-K Event Results of operations
- 8-K Event Executive or director change
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 8-K Event Other events
Page 3 of 45 · 895 filings